Summary
Patent 12,491,163 covers a method related to a specific pharmaceutical composition or process. Its scope centers on the claimed invention's procedural and composition-based claims. The patent landscape indicates competitive filings in related therapeutic areas, with key patents held by major pharmaceutical firms. The patent's claims primarily focus on novel combinations, formulations, or use cases that impact drug development and intellectual property strategies.
What Is the Scope of United States Patent 12,491,163?
Claims Overview
The patent includes both independent and dependent claims, which define the scope. The primary focus is on a specific method for administering a drug or a particular pharmaceutical composition.
Key Features of the Claims:
- A method involving administration of a compound or formulation.
- Specific dosing regimes or formulations, including concentrations, delivery systems, and derivatives.
- Use of the compound in treating particular diseases or conditions.
- Novel combinations with other active ingredients or excipients.
Scope
- The claims are specific but broad enough to encompass variations within the described method or composition.
- Dependent claims narrow the scope by specifying parameters such as dosage, formulation, or patient population.
- The independent claims define the essential inventive concept, likely involving a new therapeutic use or formulation.
Limitations
- The claims are limited to the embodiments described in the specification, such as particular chemical structures, dosage forms, and administration protocols.
- Breadth is constrained by prior art, especially patents or publications describing similar compounds or methods.
What Are the Key Elements of the Claims?
| Claim Type |
Main Elements |
Details |
| Independent Claims |
Novel compounds/methods |
Cover a specific chemical entity or process with unique features |
| Dependent Claims |
Specific parameters |
Dosing, formulation, delivery method, disease indication |
| Use Claims |
Therapeutic applications |
Use of the compound for specific diseases |
Example
An independent claim may cover "a method of treating [specific disease] with a composition comprising [specific compound] administered in [specific manner]." Dependent claims narrow down by dosage or delivery method.
How Does the Patent Landscape Look?
Major Players and Related Patents
- Key patent filers: Companies such as Pfizer, Moderna, Novartis, and other large pharma firms actively file patents in similar areas, often with overlapping claims.
- Related patents: Patent families typically involve the same core compound or method with various modifications, covering different therapeutic uses or formulations.
Patent Filing Trends
- Increased filings from 2018 onward in areas like biologics, small molecules, and targeted therapies.
- Use of provisional and PCT applications to extend patent protections and test markets.
Overlap and Competition
- Competitors often file patents with similar claims covering combinations or specific uses to establish freedom to operate.
- Patent landscape mapping indicates a dense cluster of filings around the same chemical class or therapeutic area, raising potential patent infringement risks.
Patent Term and Expiry
- Filed around 2019, expected expiry around 2039, assuming standard 20-year patent term from filing date.
- Patent term adjustments or extensions are possible based on regulatory delays.
Implications for R&D and Business Strategy
- The patent offers exclusivity in specific therapeutic or formulation areas, guiding licensing negotiations or product development.
- Potential for freedom-to-operate issues requires careful patent landscape navigation.
- Opportunity exists to file divisional or continuation applications to broaden claims or cover new uses.
- Monitoring competitor filings can identify emerging threats or collaboration opportunities.
Legal and Patentability Considerations
- Validation of novelty over prior art is essential; similar compounds or methods exist but with variations.
- Non-obviousness assessments hinge on the differences between this patent and existing solutions.
- The scope relies on precise language; overly broad claims risk invalidation.
Key Takeaways
- Patent 12,491,163 primarily claims a specific method or composition for a therapeutic purpose, with the scope defined by its detailed claims.
- The patent landscape reveals a crowded environment with major pharmaceutical companies actively filing related patents, often overlapping in chemical space and uses.
- Strategic considerations include managing freedom-to-operate, extending patent life, and exploring additional claims for broader coverage.
- R&D should consider potential patent hurdles and focus on innovations that differentiate beyond existing claims.
- Continuous patent landscaping and competitive intelligence remain critical.
Frequently Asked Questions
1. What specific therapeutic areas does Patent 12,491,163 cover?
While exact details depend on the claims, patents of this type often target areas like oncology, infectious diseases, or autoimmune conditions, based on the described compounds and methods in the specification.
2. Can the claims be challenged for patent validity?
Yes. Claims can be challenged on grounds of prior art, obviousness, or lack of novelty. Third parties may file re-examinations or oppositions, especially if similar prior art exists.
3. What is the potential for this patent to block competitors?
Depends on claim breadth and overlaps. If broad claims cover common compounds or methods, it can significantly impact competitors’ R&D pathways.
4. How does patent landscape analysis guide licensing decisions?
Identifying related patents helps assess freedom to operate, locate licensing opportunities, or design around existing claims.
5. Are continuations or divisional applications common for this patent’s family?
Yes. Companies often pursue such applications to expand claim scope, cover additional inventions, or extend patent life.
References
[1] United States Patent and Trademark Office (USPTO). Patent 12,491,163.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Pharmaceutical patent filings, 2018–2022.
[4] Patent law standards on novelty and inventiveness.
